Cardiac Abnormalities after Aneurysmal Subarachnoid Hemorrhage: Effects of B-Blockers and Angiotensin-Converting Enzyme Inhibitors
Elizabeth Crago, RN, PhD, Kelly Kerris, RN, BSN, Chien-Wen J. Kuo, MS, Paula Sherwood, RN, PhD, Marilyn Hravnak, RN, CRNP, PhD, David Crippen, MD, and Michael Horowitz, MD
Cardiac Abnormalities after Aneurysmal Subarachnoid Hemorrhage: Effects of B-Blockers and Angiotensin-Converting Enzyme Inhibitors: Read Article
Get CNE

Learning Objectives

At the completion of this program, you will be able to:
  • Describe the cardiac abnormalities that occur after aneurysmal subarachnoid hemorrhage.
  • Identify the indications for use of angiotensin-converting enzyme (ACE) inhibitors and ß-blockers.
  • Discuss the effects ACE inhibitors and ß-blockers have on cardiac abnormalities after aneurysmal subarachnoid hemorrhage.

Continuing Education Information

CE ID: A1423012
Total Contact Hours: 1.00
Pharma Hours: 0.25
Synergy Cat: A
Test Expires: 1/1/2016

Description

Cardiac Abnormalities after Aneurysmal Subarachnoid Hemorrhage: Effects of B-Blockers and Angiotensin-Converting Enzyme Inhibitors

Publication/Sponsor Information


American Journal of Critical Care is an official publication of the American Association of Critical-Care Nurses (AACN), and copyright belongs to AACN. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage retrieval system without permission of AACN. For all permission requests, please contact the Copyright Clearance Center, Customer Service, 222 Rosewood Drive, Danvers, MA 01923. (978) 750-8400. The statements and opinions contained herein are solely those of individual contributors and not of the editors, AACN, or The InnoVision Group. The editors, AACN, and The InnoVision Group assume that articles emanating from a particular institution are submitted with the approval of the requisite authority, including all matters pertaining to human studies and patient privacy requirements.

You have currently started taking the test for . To continue your test in progress, select Return to Test. To abandon this test select Cancel.

Your Feedback